Cellframe is projected to rise to $0.0627 by 2027, a +79% move from its current price of $0.0351. CELL is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean sell. Market sentiment sits at 26/100 (Fear) on the Fear & Greed Index.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via CoinGecko & CoinMarketCap · updated 7/1/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 12 | $0.0331 | $0.0351 | $0.0371 | -0.19% |
| Jul 13 | $0.0323 | $0.035 | $0.0379 | -0.38% |
| Jul 14 | $0.0317 | $0.0349 | $0.0385 | -0.58% |
| Jul 15 | $0.0312 | $0.0349 | $0.039 | -0.77% |
| Jul 16 | $0.0307 | $0.0348 | $0.0394 | -0.96% |
| Jul 17 | $0.0303 | $0.0347 | $0.0398 | -1.15% |
| Jul 18 | $0.0299 | $0.0347 | $0.0402 | -1.34% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.0299 | $0.0347 | $0.0402 | -1.34% |
| Week 2 | $0.0277 | $0.0342 | $0.0422 | -2.66% |
| Week 3 | $0.0261 | $0.0337 | $0.0436 | -3.96% |
| Week 4 | $0.0247 | $0.0333 | $0.0448 | -5.24% |
| Week 5 | $0.0236 | $0.0328 | $0.0457 | -6.51% |
| Week 6 | $0.0225 | $0.0324 | $0.0466 | -7.76% |
| Week 7 | $0.0216 | $0.032 | $0.0473 | -9.00% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Cellframe Network is a scalable, open-source, next-generation platform for building and bridging blockchains and services secured by post-quantum encryption. It provides an environment for enterprises and developers to build a vast array of products ranging from simple low-level t-dApps to whole other blockchains on top of Cellframe Network.
Built from scratch in plain C, t-dApps built on the Cellframe SDK can be executed on anything from enterprise-level mainframes to a smart fridge, enabling developers to build a wide range of applications. The system is secured by post-quantum cryptography and features a unique implementation of dual-layer sharding, conditional transactions and multiparty computations for fast, interoperable and economical transactions secured by integrated quantum safety measures.
Cellframe operates as a scalable, open-source blockchain platform with a focus on cross-chain capabilities and quantum-resistant security.
The asset currently trades at $0.0351 with a market capitalization of $1.31M and is ranked 2569th by market cap.
Its all-time high reached $7.21, while the all-time low was $0.0299. The forecast shows a path of gradual progression with several bullish years ahead, including notable upside in 2027-2032 and beyond.
A major floor 30.9% below — a decisive break under it would weaken the trend.
The nearest floor, 12.2% below — buyers have tended to step in here.
The nearest ceiling, 24.2% above — a clean break opens room to run.
A major ceiling 104.1% above — clearing it would confirm fresh momentum.
Key CELL support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of CELL market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.0334 | Buy | $0.0336 | Buy |
| MA 10 | $0.033 | Buy | $0.0334 | Buy |
| MA 20 | $0.0336 | Buy | $0.0342 | Buy |
| MA 50 | $0.0387 | Sell | $0.0387 | Sell |
| MA 100 | $0.0461 | Sell | $0.0481 | Sell |
| MA 200 | $0.0661 | Sell | $0.0765 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 50.10 | Neutral |
| Stoch RSI (14) | 100.00 | Sell |
| CCI (20) | 59.90 | Neutral |
| Williams %R (14) | -3.03 | Info |
| MACD (12,26,9) | 0.00 | Buy |
| ROC (12) | 14.22 | Buy |
| Bollinger %B (20,2) | 0.70 | Neutral |
| Stochastic %K (14) | 96.97 | Sell |
| TRIX (15) | -0.84 | Sell |
| Awesome (5,34) | -0.00 | Sell |
| Ultimate (7,14,28) | 50.72 | Neutral |
| Momentum (10) | 0.00 | Buy |
| Aroon Osc (25) | -44.00 | Sell |
| Hull MA (9) | 0.03 | Buy |
| ADX (14) | 15.87 | Neutral |
| ATR (14) | 0.00 | Info |
The 30-day technical picture is currently NEUTRAL, with RSI(14) at 50.
The price is trading around the SMA50 of $0.0388 and well below the SMA200 of $0.0661. Immediate support stands at $0.0308 and resistance at $0.0436. The 30-day range spans from $0.0258 to $0.0477, indicating modest near-term volatility.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.0308 | $0.0351 | $0.0476 | 0% | Neutral | |
| $0.0454 | $0.0627 | $0.0937 | +79% | Bullish | |
| $0.0442 | $0.0649 | $0.1033 | +85% | Bullish | |
| $0.0225 | $0.0347 | $0.058 | -1% | Neutral | |
| $0.0318 | $0.0515 | $0.0896 | +47% | Bullish | |
| $0.0428 | $0.0726 | $0.1307 | +107% | Bullish | |
| $0.0427 | $0.0756 | $0.1402 | +115% | Bullish | |
| $0.0378 | $0.0696 | $0.1328 | +98% | Bullish | |
| $0.0264 | $0.0507 | $0.0991 | +44% | Bullish | |
| $0.043 | $0.0856 | $0.1713 | +144% | Bullish | |
| $0.048 | $0.1067 | $0.2346 | +204% | Bullish | |
| $0.0284 | $0.063 | $0.145 | +79% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $0.0308 | $0.0351 | $0.0511 | +0.00% |
| August 2026 | $0.0275 | $0.0334 | $0.0426 | -4.77% |
| September 2026 | $0.0239 | $0.0295 | $0.0382 | -11.89% |
| October 2026 | $0.03 | $0.0375 | $0.0494 | +27.23% |
| November 2026 | $0.031 | $0.0391 | $0.0523 | +4.33% |
| December 2026 | $0.0276 | $0.0352 | $0.0476 | -10.13% |
Click any year to see its month-by-month CELL forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The CELL price prediction for 2026 points to an average of $0.0351 (low $0.0308, high $0.0476) — a potential gain of 0% on today's $0.0351. A consolidation phase looks the most probable path here.
In 2027, CELL is projected to trade between $0.0454 and $0.0937, averaging $0.0627 — a potential gain of +79% from today's $0.0351. That is up +79% on the projected 2026 average. Momentum favours further upside here.
Cellframe's 2028 outlook centres on $0.0649, within a $0.0442 to $0.1033 range. That is up +4% on the projected 2027 average. That marks a +85% change versus current levels. Buyers look set to stay in control over this stretch.
By 2029, CELL could reach as high as $0.058, with a base case around $0.0347 and support toward $0.0225 — roughly -1% from $0.0351. Price action looks broadly range-bound.
Expect CELL to range from $0.0318 to $0.0896 through 2030. The $0.0515 average target implies a +47% move from current prices. That is up +48% on the projected 2029 average. Buyers look set to stay in control over this stretch.
The CELL price prediction for 2031 points to an average of $0.0726 (low $0.0428, high $0.1307) — a potential gain of +107% on today's $0.0351. Momentum favours further upside here.
In 2032, CELL is projected to trade between $0.0427 and $0.1402, averaging $0.0756 — a potential gain of +115% from today's $0.0351. That is up +4% on the projected 2031 average. Buyers look set to stay in control over this stretch.
Cellframe's 2033 outlook centres on $0.0696, within a $0.0378 to $0.1328 range. That is -8% versus the projected 2032 average. That marks a +98% change versus current levels. Momentum favours further upside here.
By 2034, CELL could reach as high as $0.0991, with a base case around $0.0507 and support toward $0.0264 — roughly +44% from $0.0351. Buyers look set to stay in control over this stretch.
Expect CELL to range from $0.043 to $0.1713 through 2035. The $0.0856 average target implies a +144% move from current prices. That is up +69% on the projected 2034 average. Momentum favours further upside here.
The CELL price prediction for 2040 points to an average of $0.1067 (low $0.048, high $0.2346) — a potential gain of +204% on today's $0.0351. Buyers look set to stay in control over this stretch.
In 2050, CELL is projected to trade between $0.0284 and $0.145, averaging $0.063 — a potential gain of +79% from today's $0.0351. That is -41% versus the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in CELL today (≈ 28,473.139295 CELL) could be worth
$1,794.94
+$794.94 (+79%) by 2050 · US Dollar
Based on the average projected CELL price of $0.06 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in CELLwould be worth at today's price.
$1,000 invested in CELL on Jul 1, 2025 (≈ 3,519.135367 CELL) would be worth
$123.59
-$876.41 (-87.6%) today · 0.12× · US Dollar
Based on a CELL entry price of $0.284161 vs. today's $0.035121.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.035371 | $992.93 | -0.7% |
| 1 month ago | $0.044887 | $782.43 | -21.8% |
| 3 months ago | $0.076162 | $461.14 | -53.9% |
| 6 months ago | $0.097356 | $360.75 | -63.9% |
| 1 year ago | $0.284161 | $123.59 | -87.6% |
| All time (1.1y) ago | $0.335366 | $104.72 | -89.5% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our CELL forecast.
Our base-case forecast reaches $0.07 around 2031.
Implied market cap at $0.07: $2.6M
Forecasts project a multi-year path with varying upside.
In 2027 the avg price is $0.0627 with a max of $0.0937 and a ROI of 78.5%. In 2028 the avg is $0.0649 with a max of $0.1033 and a ROI of 84.8%.
By 2030 the avg reaches $0.0515 with a max of $0.0896 and a ROI of 46.7%. By 2040 the avg is $0.1067 with a max of $0.2346 and a ROI of 203.8%. In 2050 the avg is $0.063 with a max of $0.145 and a ROI of 79.5%. Sentiment remains bullish in many years, with risk factors that include the volatility inherent in small-cap assets and market cycles.
Tap a question to reveal the answer.
The 2030 avg price is $0.0515 with a ROI of 46.7%.
Forecasts show several bullish years and positive ROIs (e.g., 78.5% in 2027, 84.8% in 2028, 106.8% in 2031, 115.2% in 2032, and 203.8% in 2040), but these are estimates and not guarantees.
Yes, the forecast includes max values above $0.10 in multiple years (e.g., 2031 max $0.1307 and 2032 max $0.1402).
All-time high is $7.21 and all-time low is $0.0299.
Current price is $0.0351 and market cap is $1.31M; the rank is 2569.
Cellframe Community Discussion
0Share your Cellframe price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.